Vigneswaran and co-workers showed that VP acts as an inducer of apoptosis of patient-derived GBM cells that successfully suppressed expression of YAP/TAZ transcriptional target genes, and had significant survival benefit in an orthotopic xenograft GBM model [361]. This evidence concerns the gene YAP1 and glioblastoma.